Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Psychosis Market?

The market for psychosis has seen significant growth in the past few years. It is predicted to expand from $9.88 billion in 2024 to $10.46 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. This growth during the historical period can be credited to the rise in mental health conditions, the increasing demand for mental health therapeutics, the widespread acceptance of typical antipsychotics, the growing use of cognitive behavioral therapy, and the presence of stress-provoking global and economic conditions.

The market for psychosis is projected to experience robust expansion in the upcoming years, reaching a total value of $13.02 billion by 2029 with a compound annual growth rate (CAGR) of 5.6%. The surge in this time frame can be assigned to factors such as increasing stress and related risk elements, escalating mental health issues due to lifestyle alterations, initiatives by governments, the increased uptake of mindfulness practices and therapy sessions, and the escalation in mental health research and innovation-led therapy investment. Key trend movements within this forecast period include the emergence of new drug treatments, advances in diagnosis technologies, the invention of innovative injectable drugs, biomarkers utilization, and the growth in demand for personalized medication.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

What Growth-Enabling Forces Are Impacting The Psychosis Market?

The rise in cases of mental health disorders is anticipated to stimulate the expansion of the psychosis market. Mental health disorders are conditions that affect an individual’s mood, cognitive function, behavior, and overall psychological health. The escalation in mental health disorder cases can be attributed to increasing stress levels, changes in lifestyle, social isolation, economic strains, and genetic susceptibility. The management of psychosis offers support to patients grappling with mental health problems via early detection, medical intervention, and targeted treatments, resulting in a heightened utilization of antipsychotic medications and therapy alternatives. For example, as reported by the National Alliance On Mental Illness (a U.S.-based organization) in 2024, approximately 600,000 hospitalizations annually within the U.S. age group of 18-44 are due to psychosis spectrum and mood disorders. Therefore, the upward trend in mental health disorder cases is fueling the growth of the psychosis market.

How Does The Psychosis Market Differ By Segment?

The psychosismarket covered in this report is segmented –

1) By Product: Tablet; Capsule; Injection

2) By Disease Type: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Disease Types

3) By Distribution Channel: Online; Offline

4) By End-User: Hospitals; Healthcare Clinics; Speciality Clinics; Other End-Users

Subsegments:

1) By Tablet: Antipsychotic Tablets; Mood Stabilizer Tablets

2) By Capsule: Antipsychotic Capsules; Antidepressant Capsules

3) By Injection: Long-acting Injectable Antipsychotics; Short-acting Injectable Antipsychotics

How Are Global Trends Impacting The Development Of The Psychosis Market?

In the psychosis market, major players are concentrating on advancing virtual reality (VR) psychological therapies to enhance treatment results through interactive, tailored mental health interventions. VR psychological therapy immerses patients in controlled, computer-generated settings designed to reduce distress, boost cognitive functioning, and improve social skills via guided therapeutic sessions. For instance, in April 2022, OxfordVR, a US digital therapeutics company, launched gameChangeVR, which supports patients through cognitive behavioral therapy (CBT) in immersive virtual environments. Delivered across six weekly sessions, this automated VR therapy demonstrated significant improvements, especially for individuals with severe psychological symptoms, alleviating paranoia and enhancing overall quality of life. This technology holds promise to broaden access to effective mental healthcare by addressing clinician shortages and providing scalable treatment options for millions with severe mental illnesses.

Who Are The Most Influential Companies In The Psychosis Market?

Major companies operating in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

Which Region Is Leading Innovation In The Psychosis Market?

North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp

Browse Through More Reports Similar to the Global Psychosis Market 2025, By The Business Research Company

Residential Substance Abuse And Mental Health Facilities Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

Mental Health Apps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model